scholarly journals Current trend of worsening prognosis of prostate small cell carcinoma: A population‐based study

2019 ◽  
Vol 8 (15) ◽  
pp. 6799-6806 ◽  
Author(s):  
Jili Wang ◽  
Xiaoyan Liu ◽  
Yan Wang ◽  
Guoping Ren
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Current Trend ◽  
Population Based ◽  
Small Cell ◽  
Population Based Study

Small cell carcinoma of the pancreas: population-based study of a rare tumor using the National Cancer Data Base

2015 ◽  
Vol 221 (4) ◽  
pp. e22
Author(s):  
Tommy Ivanics ◽  
John R. Bergquist ◽  
Christopher Shubert ◽  
Elizabeth B. Habermann ◽  
Rory L. Smoot ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Data Base ◽  
Small Cell Carcinoma ◽  
Population Based ◽  
National Cancer Data Base ◽  
Small Cell ◽  
Rare Tumor ◽  
Population Based Study ◽  
Carcinoma Of The Pancreas ◽  
Cancer Data

Survival of patients with small cell carcinoma of the prostate during 1973-2003: a population-based study

2011 ◽  
Vol 109 (6) ◽  
pp. 824-830 ◽  
Author(s):  
Sundeep Deorah ◽  
Marepalli B. Rao ◽  
Rachna Raman ◽  
Krishnanath Gaitonde ◽  
James F. Donovan
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Population Based ◽  
Small Cell ◽  
Population Based Study ◽  
Carcinoma Of The Prostate

SURVIVAL OF PATIENTS WITH SMALL CELL CARCINOMA OF THE PROSTATE DURING 1973-2003: A POPULATION BASED STUDY

2009 ◽  
Vol 181 (4S) ◽  
pp. 63-63 ◽  
Author(s):  
Sundeep Deorah ◽  
Krishnanath Gaitonde ◽  
Rachna Raman ◽  
Marepalli B Rao ◽  
James F Donovan
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Population Based ◽  
Small Cell ◽  
Population Based Study ◽  
Carcinoma Of The Prostate

scholarly journals Clinical features and prognosis of primary tracheal small cell carcinoma: a population-based analysis

2020 ◽  
Vol 9 (2) ◽  
pp. 882-890
Author(s):  
Kun Chen ◽  
Zhihao Yang ◽  
Xinbo Zhang ◽  
Tianhao Zhao ◽  
Xiang Zhang ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Clinical Features ◽  
Population Based ◽  
Small Cell

scholarly journals Population-based analysis of small cell carcinoma of the esophagus using the SEER database

2020 ◽  
Vol 12 (7) ◽  
pp. 3529-3538
Author(s):  
Jiangyan Li ◽  
Jun Ma ◽  
Hao Wang ◽  
Jianyong Niu ◽  
Lin Zhou
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Population Based ◽  
Small Cell ◽  
Seer Database ◽  
Carcinoma Of The Esophagus

Population-based study of the incidence, mortality and prognostic factors of small cell carcinoma of the cervix: Analysis of the Surveillance, Epidemiology and End Results database

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 5546-5546
Author(s):  
J. Chen ◽  
O. K. MacDonald ◽  
D. K. Gaffney
Keyword(s):  
Prognostic Factors ◽  
Lymph Node ◽  
Cell Carcinoma ◽  
Figo Stage ◽  
Lymph Node Involvement ◽  
Population Based ◽  
Small Cell ◽  
Cervix Uteri ◽  
Population Based Study ◽  
Node Involvement

5546 Background: Small cell carcinoma (SmC) is a rare histology of the cervix uteri that is generally associated with a poor prognosis. This is a population-based study of SmC using the Surveillance, Epidemiology and End Results (SEER). Methods: From 1977 to 2003, 290 women with SmC of the cervix uteri were identified. In addition, 27,527 patients with squamous cell carcinoma (SC) and 5231 with adenocarcinoma (AC) of the cervix were identified for comparison. The annual incidence of each histology was determined and examined for trend. The patient and disease characteristics at diagnosis were examined for each histology, and prognostic factors were evaluated for SmC. Mortality rates of SmC and other histologies were compared via log-rank tests. Results: Mean annual incidence of SmC was 0.03 per 100,000 women compared to 3.5 and 0.62 for SC and AC. A significant change in incidence was identified for SC and AC (p<0.05), but not for SmC (p=0.595). Patients with SmC were more likely to be treated with radiotherapy and to present with more advanced stage, lymph node involvement and distant metastasis than SC and AC (p<0.05). Survival rates for SmC at 2 and 5 years were 46.8% and 35.7%, which were worse compared to SC (HR 0.45; 95% CI: 0.36–0.57) and AC (HR 0.31; 95% CI: 0.25–0.39). The difference in survival is predominantly in patients with early stage, localized disease, and those treated with surgery ( Table ). Multivariate analysis of SmC, race, FIGO stage, age and hysterectomy alone significantly impacted prognosis (p<0.05), while year of diagnosis, lymph node involvement, tumor size, marital status and other treatment modality did not. Conclusions: SmC is an uncommon histologic variant of cervix cancer associated with a worse prognosis compared to SC and AC with a predilection for metastasis at diagnosis. FIGO stage, age and race are prognostic factors for survival. [Table: see text] No significant financial relationships to disclose.

Sign in / Sign up

Export Citation Format

Share Document